The effect of phosphodiesterase-5 inhibition by sildenafil citrate on inflammation and apoptosis in rat experimental colitis
Authors:
- Unal UsluUUUnal Uslu
- Feriha ErcanFEFeriha Ercan
- Mehmet Serif AydinMAMehmet Serif Aydin
- Meral YukselMYMeral Yuksel
- Ayliz Velioglu OguncAOAyliz Velioglu Ogunc
- Inci AlicanIAInci Alican
- 1 September 2011
- journal article
- Published by Elsevier in Life Sciences
- Vol. 89 (11-12) , 402-407
Abstract
No abstract availableKeywords
Funding Information
- Marmara University Scientific Research Project Commission (SAG-A-060510-0113)
This publication has 27 references indexed in Scilit:
- Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunctionUrology, 2002
- Phosphodiesterase 5 inhibitors and nitrergic transmission—from zaprinast to sildenafilEuropean Journal of Pharmacology, 2001
- Inflammatory bowel disease: Etiology and pathogenesisGastroenterology, 1998
- SILDENAFIL, A TYPE-5 CGMP PHOSPHODIESTERASE INHIBITOR, SPECIFICALLY AMPLIFIES ENDOGENOUS cGMP-DEPENDENT RELAXATION IN RABBIT CORPUS CAVERNOSUM SMOOTH MUSCLE IN VITROJournal of Urology, 1998
- Experimental models of inflammatory bowel diseaseGastroenterology, 1995
- Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo.Gut, 1994
- Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen speciesGastroenterology, 1991
- Neutrophil-mediated mucosal injuryDigestive Diseases and Sciences, 1988
- The effect of chronic ethanol ingestion on hepatic lipid peroxide, glutathione, glutathione peroxidase and glutathione transferase in ratsToxicology, 1985
- Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme MarkerJournal of Investigative Dermatology, 1982